Functional characterization of 10 CYP4A11 allelic variants to evaluate the effect of genotype on arachidonic acid ω-hydroxylation

Stokes, 1989, Blood pressure as a risk factor for cardiovascular disease. The Framingham Study–30 years of follow-up, Hypertension, 13, I13, 10.1161/01.HYP.13.5_Suppl.I13 Barri, 2006, Hypertension and kidney disease: a deadly connection, Curr Cardiol Rep, 8, 411, 10.1007/s11886-006-0098-7 Halushka, 1999, Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis, Nat Genet, 22, 239, 10.1038/10297 Zou, 1996, 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles, Am J Physiol, 270, R228 Ma, 1993, 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries, Circ Res, 72, 126, 10.1161/01.RES.72.1.126 Schwartzman, 1985, Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase, Nature, 314, 620, 10.1038/314620a0 Nowicki, 1997, 20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na+,K+-ATPase, J Clin Invest, 99, 1224, 10.1172/JCI119279 Sugimoto, 2008, A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population, Hypertension, 52, 1142, 10.1161/HYPERTENSIONAHA.108.114082 Fu, 2013, A novel polymorphism of the CYP4A11 gene is associated with coronary artery disease, Clin Appl Thromb Hemost, 19, 60, 10.1177/1076029611436197 Fu, 2013, Haplotype study of the CYP4A11 gene and coronary artery disease in Han and Uygur populations in China, Gene, 512, 510, 10.1016/j.gene.2012.10.007 Fu, 2012, Haplotype-based case-control study of CYP4A11 gene and myocardial infarction, Hereditas, 149, 91, 10.1111/j.1601-5223.2012.02247.x Gainer, 2005, Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension, Circulation, 111, 63, 10.1161/01.CIR.0000151309.82473.59 Mayer, 2005, Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy, Hypertension, 46, 766, 10.1161/01.HYP.0000182658.04299.15 Fu, 2008, A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men, J Hypertens, 26, 453, 10.1097/HJH.0b013e3282f2f10c Williams, 2011, CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow, J Hypertens, 29, 1913, 10.1097/HJH.0b013e32834aa786 Powell, 1998, Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11, J Pharmacol Exp Ther, 285, 1327 Chang, 1999, Homology modeling and substrate binding study of human CYP4A11 enzyme, Proteins, 34, 403, 10.1002/(SICI)1097-0134(19990215)34:3<403::AID-PROT12>3.0.CO;2-D Lino Cardenas, 2011, Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population, Gene, 487, 10, 10.1016/j.gene.2011.07.015 1993 Gainer, 2008, Association of a CYP4A11 variant and blood pressure in black men, J Am Soc Nephrol, 19, 1606, 10.1681/ASN.2008010063